285 related articles for article (PubMed ID: 24692356)
1. Cardiac potassium channel subtypes: new roles in repolarization and arrhythmia.
Schmitt N; Grunnet M; Olesen SP
Physiol Rev; 2014 Apr; 94(2):609-53. PubMed ID: 24692356
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of Proarrhythmic Effects of Potassium Channel Blockers.
Skibsbye L; Ravens U
Card Electrophysiol Clin; 2016 Jun; 8(2):395-410. PubMed ID: 27261830
[TBL] [Abstract][Full Text] [Related]
3. Modulation of spiral wave reentry by K(+) channel blockade.
Honjo H; Yamazaki M; Kamiya K; Kodama I
Circ J; 2007; 71 Suppl A():A26-31. PubMed ID: 17587736
[TBL] [Abstract][Full Text] [Related]
4. Theoretical possibilities for the development of novel antiarrhythmic drugs.
Varró A; Biliczki P; Iost N; Virág L; Hála O; Kovács P; Mátyus P; Papp JG
Curr Med Chem; 2004 Jan; 11(1):1-11. PubMed ID: 14754422
[TBL] [Abstract][Full Text] [Related]
5. Remodelling of cardiac repolarization: how homeostatic responses can lead to arrhythmogenesis.
Michael G; Xiao L; Qi XY; Dobrev D; Nattel S
Cardiovasc Res; 2009 Feb; 81(3):491-9. PubMed ID: 18826964
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological activation of IKr impairs conduction in guinea pig hearts.
Larsen AP; Olesen SP; Grunnet M; Poelzing S
J Cardiovasc Electrophysiol; 2010 Aug; 21(8):923-9. PubMed ID: 20163495
[TBL] [Abstract][Full Text] [Related]
7. Pharmacology of cardiac potassium channels.
Li GR; Dong MQ
Adv Pharmacol; 2010; 59():93-134. PubMed ID: 20933200
[TBL] [Abstract][Full Text] [Related]
8. Electrophysiologic changes in heart failure: focus on pacemaker channels.
Sartiani L; Stillitano F; Cerbai E; Mugelli A
Can J Physiol Pharmacol; 2009 Feb; 87(2):84-90. PubMed ID: 19234571
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of cardiac two-pore-domain K+ (K2P) channels--an emerging antiarrhythmic concept.
Schmidt C; Wiedmann F; Schweizer PA; Katus HA; Thomas D
Eur J Pharmacol; 2014 Sep; 738():250-5. PubMed ID: 24927994
[TBL] [Abstract][Full Text] [Related]
10. Cardiac ion channels and mechanisms for protection against atrial fibrillation.
Grunnet M; Bentzen BH; Sørensen US; Diness JG
Rev Physiol Biochem Pharmacol; 2012; 162():1-58. PubMed ID: 21987061
[TBL] [Abstract][Full Text] [Related]
11. Atrial selectivity of antiarrhythmic drugs.
Ravens U; Poulet C; Wettwer E; Knaut M
J Physiol; 2013 Sep; 591(17):4087-97. PubMed ID: 23732646
[TBL] [Abstract][Full Text] [Related]
12. Atrial-selective K
Ravens U
Can J Physiol Pharmacol; 2017 Nov; 95(11):1313-1318. PubMed ID: 28738160
[TBL] [Abstract][Full Text] [Related]
13. An examination of the cardiac actions of PD117,302, a κ-opioid receptor agonist.
Pugsley MK; Saint DA; Hayes ES; Abraham S; Walker MJ
Eur J Pharmacol; 2015 Aug; 761():330-40. PubMed ID: 26086860
[TBL] [Abstract][Full Text] [Related]
14. Expanding role of SK channels in cardiac electrophysiology.
Mahida S
Heart Rhythm; 2014 Jul; 11(7):1233-8. PubMed ID: 24681007
[TBL] [Abstract][Full Text] [Related]
15. Remodeling of atrial ATP-sensitive K⁺ channels in a model of salt-induced elevated blood pressure.
Lader JM; Vasquez C; Bao L; Maass K; Qu J; Kefalogianni E; Fishman GI; Coetzee WA; Morley GE
Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H964-74. PubMed ID: 21724863
[TBL] [Abstract][Full Text] [Related]
16. Specific inhibition of HCN channels slows rhythm differently in atria, ventricle and outflow tract and stabilizes conduction in the anoxic-reoxygenated embryonic heart model.
Sarre A; Pedretti S; Gardier S; Raddatz E
Pharmacol Res; 2010 Jan; 61(1):85-91. PubMed ID: 19818405
[TBL] [Abstract][Full Text] [Related]
17. Targeting potassium channels: new advances in cardiovascular therapy.
Martínez-Mármol R; Roura-Ferrer M; Felipe A
Recent Pat Cardiovasc Drug Discov; 2008 Jun; 3(2):105-18. PubMed ID: 18537761
[TBL] [Abstract][Full Text] [Related]
18. Novel anti-arrhythmic drugs for atrial fibrillation management.
Ehrlich JR; Nattel S; Hohnloser SH
Curr Vasc Pharmacol; 2007 Jul; 5(3):185-95. PubMed ID: 17627562
[TBL] [Abstract][Full Text] [Related]
19. Repolarization of the cardiac action potential. Does an increase in repolarization capacity constitute a new anti-arrhythmic principle?
Grunnet M
Acta Physiol (Oxf); 2010 Feb; 198 Suppl 676():1-48. PubMed ID: 20132149
[TBL] [Abstract][Full Text] [Related]
20. Potassium Channel Remodeling in Heart Disease.
Algalarrondo V; Nattel S
Card Electrophysiol Clin; 2016 Jun; 8(2):337-47. PubMed ID: 27261825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
